Company / Operating Margin
Arbutus Biopharma Corp Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-271.0%
FY2025
5-year range
-1236.7% / -167.8%
FY2021-FY2025
Trend
+78.1%
vs FY2024
Sector context
#103 of 136
Health Care
What the data says
Arbutus Biopharma Corp's operating margin of -271.0% is lower than 76% of companies in the Health Care sector (FY2025). Operating Margin returned to growth in FY2025 after 2 years of decline, reaching -271.0%.
Based on SEC 10-K filings.
-271.0% in FY2025 with a 5-year CAGR of +2123.0%.
Improved from -430.5% to -271.0% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -103.2pp
- 5-Year Change
- +2123.0pp
- 10-Year Change
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 136This company -271.0% Sector average -778.9%
▼
+65.2% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 78.1% year-over-year.
- Currently 508.0pp above the Health Care sector average.
- Peak operating margin was recorded in FY2022.
- Lowest operating margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -271.0% | +78.1% |
| FY2024 | -1236.7% | -187.3% |
| FY2023 | -430.5% | -156.6% |
| FY2022 | -167.8% | +74.9% |
| FY2021 | -669.1% | +72.1% |
| FY2020 | -2394.0% | -17.2% |
| FY2019 | -2043.2% | -97.1% |
| FY2018 | -1036.7% | +0.0% |
| FY2017 | -1036.7% | +96.9% |
| FY2016 | -32973.8% | -7285.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026